Legal AI in Practice: Firm Governance, Build vs. Buy Decisions, and Vendor Due Diligence — The Good Bot Podcast
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — Payments Pros – The Payments Law Podcast
Point-of-Sale Finance Series: Health Care Financing Compliance, Regulatory, and Privacy Pitfalls — The Consumer Finance Podcast
AGG Talks: Government Insight for Life Sciences Leaders | Patient Assistance Programs and the False Claims Act: Enforcement Trends and Compliance Risks for Life Sciences Companies
Health-e Law Episode 19: From AI to OBBBA: Healthcare Law Insights from the 2025 WHLC Leadership Summit with Amy Dilcher and Chi Huynh, WHLC Co-Chairs
Video Overview: Healthcare Trend Report - A Review of the Pharmacy and Drug Supply Chain Sectors
Concierge Practices: Understanding the Model and Its Unique Challenges
Beyond the Bylaws: The Medical Staff Show - How to Build Compliant and Effective Peer Review Processes into Your Bylaws, Part 2
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 264: 2026 Healthcare Industry Trends & Challenges with Lauren DeMoss and Matthew Roberts
Investors Prepare to Navigate FDA Crosswinds Ahead of the J.P. Morgan Healthcare Conference
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 263: Building NC's Innovation Ecosystem with Andrea Conner of First Flight Venture Center
Hospice Insights Podcast - Hospital to Hospice: Managing Referrals and Relationships
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 262: Breaking the “Undruggable” Barrier with Marcel Frenkel of Ten63 Therapeutics
12 Days of Regulatory Insights: Day 7 – Tobacco and Nicotine Regulatory Roundup — Regulatory Oversight Podcast
Navigating FDA's 2025 AI Guidance: Risk-Based Framework, Public Comments, and Generative Models - The Good Bot Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 261: Transforming Lives with Advanced BioMaterials with Dr. Juliana Blum of BioAesthetics
The Down-Low on Data for Value-Based Enterprises and Their Participating Providers – Diagnosing Health Care Video Podcast
The Corner Series Podcast: Scaling Medical Aesthetics
The Corner Series Podcast: Patent Investment Strategies
The Corner Series Podcast: Integration Over Aggregation in Oral Surgery
On January 7, the U.S. Court of Appeals for the First Circuit denied the federal government’s request for a stay of the nationwide preliminary injunction barring implementation of the Health Resources and Services...more
On December 23, 2025, three federal agencies released a proposed rule to make costs more transparent in health plans. The proposal aligns with an executive order that President Donald Trump issued in February 2025 to enforce...more
The One Big Beautiful Bill Act (OBBBA), enacted in July 2025, is no longer a policy debate or a future concern. It is already changing how coverage works, how Medicaid dollars flow, and how much operational friction health...more
Welcome to Alston & Bird’s introduction to biological products regulation. In this five-part intro-level series, we provide answers to a number of questions drug developers may have about the regulation and regulatory pathway...more
Key Takeaways - Targeted recruiting that doubles as patient acquisition is high‑risk. When a home health agency’s prospective employee is a Medicaid beneficiary’s surrogate decision‑maker, advertising a sign-on bonus can...more
In this episode of The Good Bot, Brett Mason sits down with Leigh Zeiser, director of AI and automation at Troutman Pepper Locke, to unpack how the firm operationalizes AI responsibly. They discuss the firm's AI portfolio —...more
House and Senate Lawmakers Reach Deal on FSGG Funding: On Sunday, lawmakers released the Fiscal Year (FY) 2026 Financial Services and General Government (FSGG) appropriations bill and joint explanatory statement. The bill...more
On January 12, the U.S. Supreme Court denied the petition for writ of certiorari in Guardian Flight, leaving in place the Fifth Circuit’s June 2025 decision that we covered in our prior post (available here). As a result,...more
2026 is bringing significant changes to Washington’s employment laws. This Update summarizes the changes taking effect on January 1, 2026, and highlights recent legal developments contributing to a rise in employment...more
In this crossover episode of Payments Pros and The Consumer Finance Podcast, guest host Taylor Gess dives into the rapidly evolving world of point-of-sale financing for medical and dental procedures with Troutman Pepper Locke...more
On January 6, the US Food and Drug Administration (FDA) released two significant updates potentially important for companies operating in the consumer health technology space....more
For CEOs, general counsels, and CTOs, the question is no longer whether patents matter. The question is whether the company has an intentional strategy to identify, capture, and deploy intellectual property in alignment with...more
UPDATE: On January 12, 2026, the federal government announced it would drop its appeal of Judge Walker’s order blocking implementation of the Pilot Program and return it back to HRSA for reconsideration. In a court filing...more
In the wake of the COVID-19 pandemic, the Centers for Medicare and Medicaid Services (CMS) made permanent several major expansions to telehealth coverage under Medicare by broadening the list of services that could be...more
In this crossover episode of The Consumer Finance Podcast and Payments Pros, guest host Taylor Gess dives into the rapidly evolving world of point-of-sale financing for medical and dental procedures with Troutman Pepper Locke...more
Newly released year-end reports from the New York Office of Cannabis Management (OCM), highlighted by CannabisWire, show a clear shift in the state’s cannabis enforcement landscape....more
Happy new year! Welcome to 2026. On behalf of my colleagues at Saul Ewing and our Health Care Group, we are pleased to share with you our fearless predictions of trends and topics that will impact our nation's health care...more
Our FDA: Drug & Device Team analyzes the Food and Drug Administration’s new guidance on Bayesian approaches to innovative drug trials, providing greater clarity on how companies may design and conduct studies....more
Earlier this week, the New York Times reported that the Trump administration plans to stop assigning dollar values to the human health benefits resulting from the imposition of national ambient air quality standards....more
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is considered the most significant expansion of the U.S. Food and Drug Administration’s (FDA) authority to regulate cosmetics since the enactment of the Food, Drug...more
Washington policymakers are increasingly aligned around expanding Medicare “site-neutral” payment policies in 2026, a shift that would pay hospital outpatient departments the same rates as physician offices for a broader set...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
The life sciences M&A market is reemerging in 2026 as a competitive arena for strategic buyers, after several years of subdued activity. ...more
In 2025, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and regulatory law. Highlights from 2025 are below...more
Compliance is never really optional, but this is especially true in healthcare; it’s the backbone of patient trust, ethical operations and organizational success. Everything from clinical care to data management is governed...more
